IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 124 filers reported holding IMMUNITYBIO INC in Q2 2021. The put-call ratio across all filers is 3.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $462,856 | -38.1% | 273,879 | +1.8% | 0.07% | -35.8% |
| Q2 2023 | $748,179 | -74.2% | 269,129 | -83.1% | 0.11% | -75.3% |
| Q1 2023 | $2,894,524 | -63.0% | 1,590,398 | +3.0% | 0.44% | -63.9% |
| Q4 2022 | $7,828,323 | +657.8% | 1,544,048 | +642.6% | 1.22% | +612.2% |
| Q3 2022 | $1,033,000 | +33.6% | 207,926 | 0.0% | 0.17% | +35.4% |
| Q2 2022 | $773,000 | -32.4% | 207,926 | +2.0% | 0.13% | -19.6% |
| Q1 2022 | $1,144,000 | +23.5% | 203,876 | +33.9% | 0.16% | +37.4% |
| Q4 2021 | $926,000 | -22.1% | 152,276 | +24.9% | 0.12% | -28.6% |
| Q3 2021 | $1,188,000 | -5.6% | 121,923 | +38.3% | 0.16% | -5.3% |
| Q2 2021 | $1,259,000 | +144.9% | 88,153 | +307.2% | 0.17% | +123.7% |
| Q1 2021 | $514,000 | – | 21,650 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Winning Points Advisors, LLC | 251,556 | $1,387,000 | 1.70% |
| ORACLE INVESTMENT MANAGEMENT INC | 315,322 | $1,567,000 | 0.89% |
| HARBOURVEST PARTNERS LLC | 335,709 | $1,668,000 | 0.54% |
| ALLEN HOLDING INC /NY | 687,571 | $3,417,000 | 0.54% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $479,000 | 0.21% |
| SHEETS SMITH WEALTH MANAGEMENT | 207,926 | $1,033,000 | 0.17% |
| Clearwater Capital Advisors, LLC | 185,911 | $924,000 | 0.13% |
| WEALTH EFFECTS LLC | 28,500 | $142,000 | 0.09% |
| Virtus ETF Advisers LLC | 35,048 | $174,000 | 0.07% |
| Vident Investment Advisory, LLC | 195,127 | $969,000 | 0.03% |